OR2P1P

Across TCGA pan-cancer cohorts, OR2P1P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated OR2P1P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR2P1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2P1P expression acts as an unfavorable survival marker.

MESO, PAAD, and THCA are the cancer types where OR2P1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.098	0.579	.001	108	view →
PAAD	OS	Tertile	All	0.164	0.619	<.001	90	view →
THCA	DFS	Tertile	II,III,IV	0.489	0.910	<.001	90	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
UCS	DFS	Tertile	All	0.151	0.467	.025	36	view →
ACC	OS	Tertile	All	0.268	0.802	.010	36	view →
KIRC	DFS	Tertile	All	0.243	0.638	.010	24	view →
BLCA	OS	Tertile	III,IV	0.218	0.591	.008	18	view →
TGCT	OS	Tertile	All	0.817	0.968	.027	18	view →
LGG	OS	Tertile	All	0.493	0.837	.004	12	view →
SKCM	OS	Tertile	All	0.507	0.787	.043	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

OR2P1P–MESO (OS)

Open the MESO breakdown →